bpc 157 fda warning not approved for human use FDA's Overreach on Compounded Peptides fda warning bpc-157 unapproved new
Description
70 Another study that included 100 tinnitus patients found zinc levels declined with aging and low levels were associated with increased tinnitus loudness and severity
In addition, BPC-157 is being investigated in relation to collagen synthesis

When to seek medical advice: Persistent or worsening injection site reactions (increasing redness, warmth, or discharge suggesting infection) Severe or persistent headaches Chest pain or palpitations Unexplained muscle weakness or cramps New or worsening neurological symptoms despite treatment Unexpected bleeding or bruising For non-emergency concerns, contact your GP or NHS 111

While many users have used BPC-157 for extended periods without immediate side effects, there is no long-term human safety data
It can be used to determine the approximate BAC of a subject